申请人:Pfizer Limited
公开号:EP0117100A1
公开(公告)日:1984-08-29
Compounds of the formula:
where R is phenyl optionally substituted by 1 to 3 substituents each independently selected from F, Cl, Br, I, trifluoromethyl, C1-C4 alkyl and C1-C4 alkoxy, or R is a 5-chloropyrid-2-yl group; and R1 is H, Cl, phenyl optionally substituted by 1 to 3 substituents each independently selected from F, Cl, Br, I and trifluoromethyl or a heterocyclic group linked by a carbon atom, and their 0-esters, O-ethers and salts are useful in the treatment of fungal infections in humans and animals and as agricultural fungicides.
式中 R 是任选被 1 至 3 个各自独立选自 F、Cl、Br、I、三氟甲基、C1-C4 烷基和 C1-C4 烷氧基的取代基取代的苯基,或 R 是 5-氯吡啶-2-基团;R1 是 H、Cl、任选被 1 至 3 个各自独立选自 F、Cl、Br、I 和三氟甲基的取代基取代的苯基或由碳原子连接的杂环基团,它们的 0-酯、O-醚和盐可用于治疗人类和动物的真菌感染,也可用作农用杀真菌剂。